Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori , Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni
2006
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Genes required for mycobacterial growth defined by high density mutagenesis
2003 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Click chemistry-facilitated comprehensive identification of proteins adducted by antimicrobial 5-nitroimidazoles for discovery of alternative drug targets against giardiasis
2020 StandoutNobel
Review of studies and guidelines on fasting and procedural sedation at the emergency department
2010
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori
2003
European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators
2010 Standout
Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline
2009
Ecological Hypothesis of Dentin and Root Caries
2016 Standout
Oral Anticoagulant Therapy
2012 Standout
Cognitive impairments in survivors of out-of-hospital cardiac arrest: A systematic review
2008
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Optimal therapy for Helicobacter pylori infections
2011
The Physiology and Metabolism of the Human Gastric Pathogen Helicobacter pylori
1998
Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest: systematic review and meta-analysis
2012
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Is the molecular basis of metronidazole resistance in microaerophilic organisms understood?
2002
Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation
2012
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Guidelines on the use and monitoring of heparin
2006
Heparin-Induced Thrombocytopenia
2006 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Prevention of Venous Thromboembolism
2004 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation
2009
Outcome, timing and adverse events in therapeutic hypothermia after out‐of‐hospital cardiac arrest
2009
Prevention of Venous Thromboembolism
2008 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Impact of the 2005 American Heart Association Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Guidelines on Out-of-Hospital Cardiac Arrest Survival
2009
Acetogenesis and the Wood–Ljungdahl pathway of CO2 fixation
2008 Standout
The i genome sequence: G genome sequence: Genetic factors for long life in the gastric mucosa
1997
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
The physiology and metabolism of Campylobacter jejuni and Helicobacter pylori
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Metabolic Pathways for Cytotoxic End Product Formation from Glutamate- and Aspartate-Containing Peptides by Porphyromonas gingivalis
2000
Modifiable Risk Factors and Atrial Fibrillation
2017
Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa
1999
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
Review of studies and guidelines on fasting and procedural sedation at the emergency department
2010
Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA + (Nitroreductase) Gene
2000
Part 9: Post–Cardiac Arrest Care
2010 Standout
What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review
2019 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Cooling for newborns with hypoxic ischaemic encephalopathy
2013 Standout
Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori
2002
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Managing non‐serious low back pain in the emergency department: Time for a change?
2017
Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation
2016
Helicobacter pyloriPhysiology Predicted from Genomic Comparison of Two Strains
1999
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes
2015 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Systematic Identification of Selective Essential Genes in Helicobacter pylori by Genome Prioritization and Allelic Replacement Mutagenesis
2001
Metabolism and Genetics of Helicobacter pylori : the Genome Era
1999
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Pyruvate Ferredoxin Oxidoreductase and Its Radical Intermediate
2003
Part 14: Pediatric Advanced Life Support
2010 Standout
Guidelines for the management of hemophilia
2012 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Works of Kirk Magee being referenced
Current management practices for patients presenting with low back pain to a large emergency department in Canada
2017
Procedural sedation and analgesia in a Canadian adult tertiary care emergency department: a case series
2006
Systematic review of randomized controlled trials of therapeutic hypothermia as a neuroprotectant in post cardiac arrest patients
2006
Heparin versus placebo for acute coronary syndromes
2008
Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance
1996
An Integrated Management Approach to Atrial Fibrillation
2016
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
2003